Analysts at Berenberg raised their target price on chemicals and sustainable technologies company Johnson Matthey from ...

Johnson Matthey's (LON:JMAT) stock is up by a considerable 56% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...

Standard published an open letter last year accusing Johnson Matthey’s board of presiding over “sustained underperformance” ...

Investing.com -- Standard Investments has cut its stake in Johnson Matthey (LON: JMAT) by half, scaling back after a ...

The global complex iron desulfurization catalyst market is witnessing robust growth, driven by stringent environmental ...

Johnson Matthey announced the appointment of Andrew Cosslett as its new non-executive chair, effective immediately following ...

The Cambridge Index advanced 268.27 points or 1.0% to close at 25,946.0, as seven out of the top ten index heavyweights ...

Johnson Matthey employs 11,600 people across more than 30 countries, including a large manufacturing plant in Royston, Hertfordshire. The market seems to welcome Standard Investments ...

Meanwhile, Johnson Matthey posted revenue of 11.67 billion pounds for the year ended March 31, down 9% on year. Its operating profit grew to 538 million pounds from 249 million pounds, ...

British autocatalyst maker Johnson Matthey is planning to sell its medical device components business as the company looks to streamline its portfolio of assets, Bloomberg News reported on Wednesday.

Johnson Matthey is in good financial health. Our model-driven credit risk assessment is moderate. The company targets a net debt (including posttax pension deficits) to EBITDA ratio of 1.5-2 times.

Johnson Matthey (JMAT.L) and state investor Finnish Minerals Group (FMG) have agreed to build a plant to produce cathode materials used in electric vehicle (EV) batteries.